Oracle Corporation (ORCL) stands as a multinational technology leader focused on database software, cloud infrastructure, and enterprise applications. Based in Austin, Texas, the company delivers integrated solutions like its Oracle Cloud Infrastructure (OCI), autonomous database, and AI-powered applications to enterprises around the world. Its business centers on subscription-based cloud services, software licenses, and hardware systems, creating steady recurring revenue from more than 275,000 customers in 145 countries.
In the crowded cloud computing space, Oracle maintains a solid foothold in enterprise software and database management, commanding about 28% market share in database publishing. From what I see, its strategic shift toward AI infrastructure—backed by a massive $553 billion RPO—sets it apart from hyperscalers like AWS and Azure. This positioning has contributed to its resilience, even as prices have risen with surging AI demand.
In the last 30 days, ORCL shares rose from around $138 to $196, delivering a +42% gain. The path was volatile but upward-trending, with quick recoveries from dips—including a low near $134.57—and peaks above $200, all supported by favorable analyst views.
Looking at the past quarter, the stock gained +25% from about $157, bouncing back from prior lows. It started range-bound due to capex concerns but trended higher after earnings, capturing wider AI enthusiasm even as year-to-date performance remained flat.
The 30-day upmove gained momentum from analyst upgrades spotlighting Oracle's critical role in AI infrastructure. Arete, for instance, upgraded ORCL to Buy with a $255 target, pointing to supply constraints that improve economics. Wedbush reiterated Outperform at $225, dismissing OpenAI concerns as an overreaction. These updates emphasized OCI's strong growth, with cloud infrastructure revenue jumping 84% to $4.9 billion in the latest quarter.
Sentiment turned positive as multi-cloud agreements with AWS and Google expanded, facilitating easier data flows and AI workloads. Even with some OpenAI growth challenges, Oracle's broad backlog and $16 billion financing for a Michigan data center addressed execution risks, fueling the steady climb. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against industry peers.
The quarter's +25% advance came from Q3 fiscal 2026 results that beat expectations: EPS of $1.79 against $1.70 forecasted, and revenue of $17.19 billion, up 22% year-over-year. Cloud revenue grew 44%, while RPO reached $553 billion, a 325% increase, underscoring robust AI demand.
Supporting factors included AI infrastructure expansions, partnerships like OpenAI's Stargate, and multi-cloud progress with AWS and Google. Institutional buying picked up as valuations reset, with forward P/E dropping to around 18—enough to offset earlier worries about capex and debt.
In my own research and trading workflow, I often turn to Tickeron’s Trending AI Robots to identify high-performing automated strategies. This page highlights the platform's top bots from hundreds available, which scan and trade thousands of tickers using diverse approaches, timeframes, and metrics. Curated by recent performance and relevance, these bots deliver data-driven signals for everything from short-term momentum to long-term trends or tech-sector plays. With strong win rates and risk-adjusted returns, they’ve helped streamline my analysis—worth exploring if you’re looking to automate parts of your process.
Looking forward, Q4 fiscal 2026 earnings around June 10 will be pivotal, with expectations for cloud growth of 46-50%. I'll be tracking AI data center builds in Michigan and Texas, RPO conversions tied to OpenAI deals, and multi-cloud integrations with AWS and Google Cloud for broader adoption. Broader elements like interest rates, AI capex cycles, supply constraints, partner execution risks, cloud competition, and AI regulations will shape the outlook. One thing that stands out is how these factors could sustain the momentum if execution holds steady.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ORCL declined for three days, in of 281 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for ORCL moved out of overbought territory on June 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator moved out of overbought territory. In of the 52 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where ORCL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
ORCL broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on May 27, 2026. You may want to consider a long position or call options on ORCL as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on May 29, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 308 cases where ORCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.149) is normal, around the industry mean (16.246). P/E Ratio (38.029) is within average values for comparable stocks, (69.525). Projected Growth (PEG Ratio) (1.339) is also within normal values, averaging (1.802). Dividend Yield (0.009) settles around the average of (0.020) among similar stocks. P/S Ratio (9.597) is also within normal values, averaging (146.649).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of a diversified line of business software products
Industry ComputerCommunications